0 results available. Select is focused ,type to refine list, press Down to open the menu,
Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide. It operates in two segments, In...
The following section summarizes insights on Johnson & Johnson's Capital Expenditures Margin:
Data is returned as a standard number. Suggested format is percent (e.g 0.171 => 17.1%). Please note, you need a Premium subscription to access data for capex_margin.
To view the full list of supported financial metrics please see Complete Metrics Listing.
Metrics similar to Capital Expenditures Margin in the efficiency category include:
Capital expenditures expressed as percent of revenue.
The capital expenditures margin measures a company’s capital expenditures as a percentage of the revenue. The formula to calculate capital expenditures margin and an example calculation for Johnson & Johnson’s trailing twelve months is outlined below:
Capital Expenditures Margin = Capital Expenditures / Total Revenue
5.0% = 4.424 B / 88.821 B
The tables below summarizes Johnson & Johnson’s performance over the last five years:
| Fiscal Year | Capital Expenditures | Revenue | Margin |
|---|---|---|---|
| 2021-01-03 | 3.347 B | 82.584 B | 4.1% |
| 2022-01-02 | 3.652 B | 78.74 B | 4.6% |
| 2023-01-01 | 4.009 B | 79.99 B | 5.0% |
| 2023-12-31 | 4.543 B | 85.159 B | 5.3% |
| 2024-12-29 | 4.424 B | 88.821 B | 5.0% |
The tables below summarizes Johnson & Johnson’s performance over the last four quarters:
| Quarter Ending | Capital Expenditures | Revenue | Margin |
|---|---|---|---|
| 2024-03-31 | 807 M | 21.383 B | 3.8% |
| 2024-06-30 | 976 M | 22.447 B | 4.3% |
| 2024-09-29 | 1.029 B | 22.471 B | 4.6% |
| 2024-12-29 | 1.612 B | 22.52 B | 7.2% |
You can read more about Capital Expenditures here.
The chart above depicts the distribution of capital expenditures margin for companies operating in the Healthcare sector in the Developed economic region. Over 2,010 companies were considered in this analysis, and 1,947 had meaningful values. The average capital expenditures margin of companies in the sector is 7.8% with a standard deviation of 23.9%.
Johnson & Johnson's Capital Expenditures Margin of 5.0% ranks in the 74.1% percentile for the sector. The following table provides additional summary stats:
| Economic Risk Region | Developed |
| Total Constituents | 2,013 |
| Included Constituents | 1,947 |
| Min | 0.0% |
| Max | 265.5% |
| Median | 1.5% |
| Mean | 7.8% |
| Standard Deviation | 23.9% |
You can find companies with similar capital expenditures margin using this stock screener.